These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25211849)
21. Wisdom from big pharma's Dr. Gloom. Interview by Abrahm Lustgarten. Garnier JP Fortune; 2005 Mar; 151(6):38. PubMed ID: 15782880 [No Abstract] [Full Text] [Related]
22. Dupixent, a New Entrant In the Asthma Lists. Reinke T Manag Care; 2018 Sep; 27(9):14. PubMed ID: 30216151 [TBL] [Abstract][Full Text] [Related]
23. How to combat Pharma's costly coupon programs. Cahn L Manag Care; 2012 May; 21(5):22-6. PubMed ID: 22670483 [No Abstract] [Full Text] [Related]
24. Market watch: Biopharma deal-making in 2014: a record year for M&A value. Micklus A; Muntner S Nat Rev Drug Discov; 2015 Feb; 14(2):84-5. PubMed ID: 25633786 [No Abstract] [Full Text] [Related]
27. Just mad about mAbs. Jacobs T Nat Biotechnol; 2002 Sep; 20(9):869. PubMed ID: 12205498 [No Abstract] [Full Text] [Related]
28. Pharma's role is not to bankroll biotech. Mackay M Nat Biotechnol; 2009 Jun; 27(6):504. PubMed ID: 19513045 [No Abstract] [Full Text] [Related]
29. Industry influence. Big Pharma's long tentacles. Aldis WL BMJ; 2010 Feb; 340():c941. PubMed ID: 20160329 [No Abstract] [Full Text] [Related]
30. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 1. Criticisms faced by the pharmaceutical industry. Abou-Gharbia M; Childers WE J Med Chem; 2013 Jul; 56(14):5659-72. PubMed ID: 23557017 [TBL] [Abstract][Full Text] [Related]
35. Why you should blame Wall Street for pharma's startup problem. Primack D Fortune; 2011 Dec; 164(9):82. PubMed ID: 22299517 [No Abstract] [Full Text] [Related]
36. Cancer drugs: swallowing big pharma's line? Coombes R BMJ; 2007 May; 334(7602):1034-5. PubMed ID: 17510150 [TBL] [Abstract][Full Text] [Related]
38. [Interests in pharmacological research are wider than big pharma's interest in this field]. van Os J Tijdschr Psychiatr; 2016; 58(2):157-8. PubMed ID: 26881352 [No Abstract] [Full Text] [Related]
39. Competitive collaboration in the pharmaceutical and biotechnology industry. Bingham A; Ekins S Drug Discov Today; 2009 Dec; 14(23-24):1079-81. PubMed ID: 19835979 [No Abstract] [Full Text] [Related]
40. What can Johnson & Johnson do to remain a giant in the health care industry? Carter T J Hosp Mark Public Relations; 2002; 14(1):93-103. PubMed ID: 12569997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]